Catalyst Wire Dossier Catalyst Wire Dossier

Medroxyprogesterone acetate injection 150 mg/1 mL

medroxyprogesterone acetate · Teva Pharmaceuticals USA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Medroxyprogesterone acetate injection 150 mg/1 mL, covering 2024-08-19 to 2024-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women [Phase 1]

See pricing